APA (7th ed.) Citation

Chang, Y., Tang, G., Wu, H., Liang, X., Liu, Y., & Zhuo, F. (2026). Efficacy and Safety of Benvitimod Compared with Halometasone in Patients with Moderate-to-Severe Chronic Hand Eczema: A Prospective, Single-Center, Parallel-Group, Open-Label Randomized Trial. Dermatology & Therapy, 16(3), 1665. https://doi.org/10.1007/s13555-026-01668-3

Chicago Style (17th ed.) Citation

Chang, Yuan, Gongfeng Tang, Haixuan Wu, Xuelei Liang, Yi Liu, and Fenglin Zhuo. "Efficacy and Safety of Benvitimod Compared with Halometasone in Patients with Moderate-to-Severe Chronic Hand Eczema: A Prospective, Single-Center, Parallel-Group, Open-Label Randomized Trial." Dermatology & Therapy 16, no. 3 (2026): 1665. https://doi.org/10.1007/s13555-026-01668-3.

MLA (9th ed.) Citation

Chang, Yuan, et al. "Efficacy and Safety of Benvitimod Compared with Halometasone in Patients with Moderate-to-Severe Chronic Hand Eczema: A Prospective, Single-Center, Parallel-Group, Open-Label Randomized Trial." Dermatology & Therapy, vol. 16, no. 3, 2026, p. 1665, https://doi.org/10.1007/s13555-026-01668-3.